Nurofen Back Pain (Ibuprofen)

Ibuprofen, the active ingredient in Nurofen Back Pain, is a nonsteroidal anti-inflammatory drug (NSAID) presented as an oral formulation for oral use. It reduces inflammation and alleviates pain associated with back discomfort and mild to moderate musculoskeletal conditions in adults. The product is available in standard tablet strengths for convenient dosing.

GNH USA supplies Nurofen Back Pain as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies, and clinics worldwide, ensuring consistent quality and regulatory compliance across markets and reliable supply chains.

Ibuprofen, an NSAID, is used to manage pain and inflammation in musculoskeletal conditions.

Back pain: provides relief of pain and reduces inflammation in the lumbar region. Musculoskeletal pain: alleviates mild to moderate pain associated with strains, sprains, and overuse injuries. Inflammation: decreases localized swelling and discomfort in affected tissues.

Common Side Effects: - Stomach upset or dyspepsia - Nausea - Dizziness - Headache

Serious or Rare Side Effects: - Gastrointestinal bleeding or ulceration - Severe allergic reaction (anaphylaxis) - Kidney impairment or reduced renal function

Before using ibuprofen, consider the following precautions: - Assess gastrointestinal risk: avoid in patients with active ulcers or a history of GI bleeding. - Evaluate cardiovascular status: use with caution in individuals with heart disease or hypertension. - Monitor renal function: adjust use in patients with impaired kidney function. - Avoid concurrent use with other NSAIDs, anticoagulants, or corticosteroids unless directed by a healthcare professional. - Store at ambient temperature below 25°C: keep in the original pack, protect from moisture.

Ibuprofen may interact with several medicines. Review the following before co‑administration:

Major Interactions (Avoid): - Anticoagulants (e.g., warfarin): increased risk of bleeding. - Lithium: ibuprofen can raise lithium serum concentrations. - Methotrexate: reduced clearance may lead to toxicity.

Moderate Interactions (Monitor Closely): - Diuretics: potential for reduced renal perfusion. - Selective serotonin reuptake inhibitors (SSRIs): may increase bleeding tendency.